Tumor-associated immune cells and progression-free survival in advanced endometrial cancer (EC), results from the PHAEDRA trial (ANZGOG 1601).

This article has no abstract
Epistemonikos ID: 02eae4f27f225334e6cd59498baa577e6ba7489e
First added on: Feb 13, 2025